We serve Chemical Name:prothiocarb hydrochloride CAS:19622-19-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:prothiocarb hydrochloride
CAS.NO:19622-19-6
Synonyms:PROTHIOCARB HYDROCHLORIDE;S-ethyl (3-dimethylaminopropyl)thiocarbamate hydrochloride;S-ethyl N-[3-(dimethylamino)propyl]carbamothioate hydrochloride (1:1)
Molecular Formula:C8H19ClN2OS
Molecular Weight:226.76700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.013g/cm3
Index of Refraction:
PSA:57.64000
Exact Mass:226.09100
LogP:2.59370
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2588
Packing Group:III
Contact us for information like PROTHIOCARB HYDROCHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,S-ethyl N-[3-(dimethylamino)propyl]carbamothioate hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,PROTHIOCARB HYDROCHLORIDE Use and application,S-ethyl N-[3-(dimethylamino)propyl]carbamothioate hydrochloride (1:1) technical grade,usp/ep/jp grade.
Related News: A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. (5α,17β)-17-Methylandrost-2-en-17-ol manufacturers SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 3-amino-1,3-diazaspiro[4.5]decane-2,4-dione suppliers Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. m-phthaloyl chloride vendor & factory.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 3-amino-1,3-diazaspiro[4.5]decane-2,4-dione suppliers Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. m-phthaloyl chloride vendor & factory.
